fda warning letters glp-1 compounders september 2025 FDA Sends Warning Letters to More Than 50 GLP-1 Compounders and Manufacturers

FDA issues 30 warning letters to online GLP-1 compounders

27.03

★★★★☆4.8 (126)

Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP-1 compounding while @martymakary is photographed holding bootleg #

27.50

★★★★★4.9 (98)

Today, the FDA established a “green list” import alert to help stop potentially dangerous GLP-1 active pharmaceutical ingredients from unverified foreign sources from entering the U.S. market. The agency will continue to

25.16

★★★★★5.0 (157)

FDA Green List GLP-1 Alert

29.54

★★★★★4.7 (84)

Trends In FDA FY 2025 Warning Letters

20.83

★★★★★4.9 (203)

September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns FDA – Partnership for Safe Medicines

20.67

★★★★★5.0 (176)

The FDA is cracking down on ‘misleading’ compounded GLP-1s from telehealth companies., Compounded weight loss drugs are not FDA-approved, which means the agency does not review their safety,

25.93

★★★★★4.8 (132)